| Deutschland | Türkei | Österreich | |
| Plasmapherese | von $2,200 | von $1,200 | von $2,000 |
| Nabelschnurblutbehandlung | von $10,000 | von $5,000 | von $7,500 |
| Intravenöse Kurkumin-Therapie | von $400 | von $350 | von $350 |
| Therapeutische Apherese | - | von $1,350 | - |
| Selektive Apherese | - | von $1,550 | - |
Bookimed erhebt keine zusätzlichen Gebühren für Immunologie-Behandlungspreise. Die Preise stammen aus den offiziellen Preislisten der Kliniken. Sie zahlen direkt in der Klinik für Ihre Behandlung bei Ihrer Ankunft im Land.
Bookimed setzt sich für Ihre Sicherheit ein. Wir arbeiten nur mit medizinischen Einrichtungen zusammen, die hohe internationale Standards in der Immunologie Behandlung einhalten und über die notwendigen Lizenzen verfügen, um internationale Patienten weltweit zu behandeln.
Bookimed bietet kostenlose fachliche Unterstützung. Ein persönlicher medizinischer Koordinator unterstützt Sie vor, während und nach Ihrer Behandlung und hilft Ihnen bei allen Fragen. Sie sind nie allein auf Ihrer Immunologie Behandlungsreise.
Dr. Bilal Elbey besitzt die deutsche ärztliche Approbation. Er hat eine klinische Weiterbildung in Neurologie und Psychiatrie am Klinikum Wahrendorff und an der Medizinischen Hochschule Hannover (MHH) in Hannover absolviert.
Dieses Fachwissen setzt er in der Haarwiederherstellung ein. Er bietet individuelle Behandlungspläne auf Grundlage einer gründlichen Bewertung, mit klarem Fokus auf Sicherheit und Ergebnisqualität.
Er war an mehreren klinischen Forschungsprojekten beteiligt. Seine wissenschaftlichen Arbeiten sind in PubMed und Google Scholar gelistet. In seinen Behandlungen hält er sich an aktuelle medizinische Standards.
Er praktiziert in Deutschland und gewährleistet hohe Standards bei Sicherheit, Hygiene und Patientenkomfort. Internationale Patienten betreut er auf Deutsch und Türkisch.
Dr. Fox leitet die Klinik für Hämatologie, Onkologie und Palliativmedizin am BKZ Solingen – ein zertifiziertes interdisziplinäres Krebszentrum.
Prof. Elke Jaeger ist eine der führenden Onkologinnen Deutschlands, ausgezeichnet durch das Focus-Ranking, mit über 35 Jahren Erfahrung in Onkologie und Hämatologie.
Dr. Viktor Alexander Krol leitet die Abteilungen für Gastroenterologie und Innere Medizin am St. Martinus-Krankenhaus Düsseldorf und ist auf die umfassende Versorgung bei Verdauungs- und Stoffwechselerkrankungen spezialisiert.
Immunotherapy is available in Germany for many cancers but is not universal for every type. Accessibility depends on the specific tumor profile, cancer stage, and international treatment standards. Standard options include checkpoint inhibitors, CAR-T cell therapy, and personalized antitumor vaccines for melanoma, lung, and kidney cancers.
Bookimed Expert Insight: Data from high-volume centers like Charite and Nordwest Clinic shows a trend toward integrated research institutes. These clinics often grant faster access to experimental protocols for rare tumors. Patients choosing university-affiliated hospitals typically benefit from molecular tumor boards that evaluate off-label immunotherapy eligibility more effectively than smaller facilities.
Patient Consensus: Patients with melanoma or lung cancer find access relatively straightforward, though others note that early-stage cases sometimes face stricter approval hurdles. It is widely suggested to bring full molecular testing results, such as PD-L1 status, to the first consultation to avoid diagnostic delays.
Dendritic cell therapy in Germany is a safe immunotherapy with high tolerability. Most patients experience only mild flu-like symptoms for 48 hours. The procedure uses a patient's own cells to avoid tissue damage. Procedures follow EU-GMP quality standards and undergo annual government audits.
Bookimed Expert Insight: German clinics specializing in anticancer vaccines often integrate therapy with molecular diagnostics. Data shows that centers like Nordwest Clinic, which serves 61,000+ patients annually, offer better safety. Their high volume allows for refined protocols that reduce the risk of immune-related inflammation. Patients should prioritize clinics with on-site GMP-certified laboratories to ensure vaccine purity.
Patient Consensus: Many patients find the side effects much easier to handle than traditional chemotherapy. It is important to treat this as an add-on therapy and verify clinic protocols through official registries before starting.
German clinics provide advanced immunotherapy including checkpoint inhibitors, CAR-T cell therapy, and therapeutic antitumor vaccines. Specialists use molecular diagnostics like PD-L1 testing to match treatments to genetic profiles. Facilities like Nordwest Clinic and Charité Berlin offer these therapies for various cancers and immunological disorders.
Bookimed Expert Insight: Data shows that top German centers like Nordwest Clinic integrate research institutes directly into patient care. This allows doctors like Prof. Dr. Elke Jaeger to implement therapeutic vaccines that are often unavailable elsewhere. This seamless transition from lab to clinic significantly speeds up access to new treatments.
Patient Consensus: Patients note that detailed tumor profiling is a vital first step. They often mention that while response times vary, connecting with specific support communities helps manage unpredictable side effects like fatigue or immune reactions.
Your stay for immunology in Germany depends on the complexity of the treatment protocol. Diagnostic check-ups often take a few hours. Inpatient treatments average 7 days. Complex therapies like stem cell transplants or intensive immunotherapy typically require 3 to 6 weeks for monitoring and stabilization.
Bookimed Expert Insight: Academic hospitals like Charité - Universitätsmedizin Berlin or Nordwest Clinic handle massive patient volumes. Charité alone treats over 845,000 patients annually. This high volume allows these centers to streamline diagnostic timelines. Patients often complete exhaustive immunology workups in 3 days rather than weeks.
Patient Consensus: Patients note it is important to plan a 1 week buffer for potential treatment delays. Many coordinate with doctors back home for follow-up care to keep their time in Germany under 12 days.
International admission for immunology programs in Germany requires a valid passport, academic transcripts, and certified degree certificates. Non-European Union applicants often need an Apostille or APS certificate. Standardized English or German language proficiency scores and proof of financial support are mandatory for all candidates.
Bookimed Expert Insight: Focus on clinics and research hubs with high patient volumes to gauge program strength. Charité - Universitätsmedizin Berlin serves over 845,000 patients annually and is Europe's most famous university hospital. Institutions with this level of clinical exposure often provide superior research networking opportunities for immunology students.
Patient Consensus: Patients and students note that German bureaucracy is very strict. Many emphasize starting the APS certification and document translation process at least 6 months early to avoid missing deadlines.
Patients traveling for immunology in Germany typically require a Schengen visa (Type C) for treatments under 90 days. You must specify medical intent during your application. For longer therapies like intensive stem cell protocols, a National visa (Type D) is necessary to avoid legal complications.
Bookimed Expert Insight: German university hospitals like Charite - Universitätsmedizin Berlin or Nordwest Clinic (Krankenhaus) handle high patient volumes, with Charite seeing over 800,000 people annually. Because of this scale, their international departments are highly efficient at issuing the specific 'medical invitation' letters required by embassies. Securing this letter early is the most critical step to prevent visa delays for complex immunology cases.
Patient Consensus: Patients note that while a standard tourist visa works for quick check-ups, having an official medical status on your visa is safer for inpatient care. They emphasize getting the hospital invitation letter immediately to ensure border agents and insurance companies recognize the visit as legitimate.